ReviewZeitschrift fur Rheumatologie2026
[Young adults with autoinflammation-What can rheumatologists expect?]
Review in Zeitschrift fur Rheumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdvances in diagnostics, molecular genetics and targeted treatment have optimized the management of patients with autoinflammatory diseases (AID). As increasing numbers of children and adolescents with AID survive into adulthood, the transition from pediatric to adult rheumatology care has become an important component. AIM OF THE STUDY: Presentation of the specific challenges and requirements of the transition of adolescents with AID from pediatric to adult rheumatology care and summary of current evidence and recommendations. MATERIAL AND
methodsNarrative review of the literature including guidelines, consensus statements, registries, cohort studies and surveys addressing transition.
resultsSuccessful transition of adolescents with AID requires an early structured and multidisciplinary process that addresses medical, psychosocial and educational needs, promotes self-management and empowerment and ensures continuity of specific care. Existing transition recommendations for chronic inflammatory rheumatic diseases are generally applicable to patients with AID; however, several AID-specific features necessitate additional considerations, such as genetic causes, relevant comorbidities and often lifelong treatment strategies involving off-label treatment. The AID-specific recommendations and data on the effectiveness of structured transition programs are so far limited. DISCUSSION: The transition of patients with AIDs from pediatric to adult care is a complex and demanding process. Close collaboration between pediatric and adult rheumatologists as well as patient-centered transition strategies, are crucial to ensure disease control, quality of life and social participation.
Indexed as
Identifiers
42803931What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.